The Therapeutic Goods
Administration (TGA), the regulator of medicines and therapeutic devices in
Australia, has announced that from 29 August 2012 the abortifacient
mifepristone (RU 486) will be listed on the Australian Register of Therapeutic
Goods (ARTG). Misoprostol, a drug that can be used in conjunction with
mifepristone but already available in Australia, has also been approved for use
in medical abortion. Medical abortion is a method of pregnancy termination that
involves the administration of a drug or drugs to induce an abortion, and is
distinct from surgical abortion.
